Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects
Clinical trial NCT04573322 · COMPLETED
Trial details
- NCT number
- NCT04573322
- Sponsor
- Diffusion Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2021-03-17
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.